What are the latest figures on the acute pharyngitis market’s size and projected CAGR?
The acute pharyngitis market size has grown strongly in recent years. It will grow from $2.67 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing incidence of viral and bacterial infections, growing healthcare awareness, advancements in diagnostic technologies, rising number of pediatric cases, increase in environmental pollutants and allergens.
The acute pharyngitis market size is expected to see rapid growth in the next few years. It will grow to $3.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to rising prevalence of influenza and streptococcal infections, increased focus on personalized medicine, growing adoption of rapid diagnostic tests, improvements in healthcare infrastructure, expanding access to healthcare in emerging markets. Major trends in the forecast period include shift towards over-the-counter treatments, increase in use of combination therapies, growth in telemedicine for pharyngitis diagnosis, rise of natural and alternative remedies, increasing preference for self-care and home-based treatments.
Get Your Free Sample of The Global Acute Pharyngitis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21082&type=smp
Which Market drivers have played a significant role in driving the acute pharyngitis market?
Rise in prevalence of influenza is expected to propel the growth of the acute pharyngitis market going forward. Influenza is attributed to infection with influenza viruses, which spread through respiratory droplets from coughs, sneezes, or contact with contaminated surfaces. The rise in prevalence of influenza is due to factors such as seasonal variations, low vaccination rates, increased human mobility, viral mutations, and weakened immunity in certain populations. Acute pharyngitis treatment helps influenza patients by alleviating throat inflammation and pain, reducing discomfort while swallowing, preventing secondary bacterial infections, and supporting overall recovery, which, when combined with antiviral medications, adequate hydration, and rest, enhances the body’s ability to fight the influenza virus more effectively. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, as of February 2025, the percentage of clinical lab tests that were positive for influenza reached 31.6%, up from 29.4% the previous week and 18.6% at the start of the year. Thus, the rise in prevalence of influenza is driving the growth of the acute pharyngitis market.
What are the key segments within the acute pharyngitis market?
The acute pharyngitis market covered in this report is segmented –
1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs, Alternative Remedies
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users
Subsegments:
1) By Antibiotics: Penicillins, Cephalosporins, Macrolides
2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs
3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups
4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
5) By Alternative Remedies: Herbal Teas, Honey-Based Solutions, Saltwater Gargles
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report
Which key players are shaping the acute pharyngitis market?
Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Glaxo Smithkline Pharmaceuticals Ltd, F. Hoffmann-La Roche AG, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Bitop AG, Hikma Pharmaceuticals, Lupin Limited, Alkem Laboratories Ltd., MEDICE Arzneimittel Pütter GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH
Which transformative trends will shape the acute pharyngitis market landscape?
Major companies operating in the acute pharyngitis market are focusing on developing antibiotics to combat bacterial infections more effectively and reduce antibiotic resistance. Antibiotics are crucial in treating acute pharyngitis caused by bacterial infections, such as streptococcus pyogenes, by eliminating the bacteria, reducing symptoms, and preventing complications such as rheumatic fever. For instance, in February 2022, Alembic Pharmaceuticals Limited, an India-based pharmaceutical company, received Abbreviated New Drug Application (ANDA) approval for Clarithromycin tablets USP, 250 mg and 500 mg from Food & Drug Administration (USFDA), a US-based government agency. This macrolide antibiotic is used to treat mild to moderate bacterial infections, including pharyngitis or tonsillitis, community-acquired pneumonia, and chronic bronchitis. The approval underscores the importance of effective antimicrobial treatments in managing acute pharyngitis and related bacterial infections.
How do regional factors impact the acute pharyngitis market, and which region is the largest contributor?
North America was the largest region in the acute pharyngitis market in 2024. The regions covered in the acute pharyngitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Acute Pharyngitis Market Report 2025 Offer?
The acute pharyngitis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Acute pharyngitis is the inflammation of the pharynx, which is the part of the throat located behind the mouth and nasal cavity. This condition results in a sore throat and accompanied by symptoms such as fever, headache, and swollen lymph nodes. It can be caused by various infections, including viral, bacterial, and fungal, with viral infections being the most prevalent.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21082
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
